Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Synthetic Cannabinoids (K2 / Spice)

Are Synthetic Cannabinoids (K2 / Spice) legal in United Arab Emirates?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Synthetic cannabinoids is a chemical class label rather than the name of one substance in the schedules, and that is the settled treatment of the label here. The dossier records «القنب الصناعي؛ الكانابينويدات الاصطناعية» as not being one chemical entry, so the Emirati result follows each proved constituent, checked against the complete schedules of Decision No. 158 of 2025. The class is the largest and fastest moving in this table, since new compounds appear continually and a class label covers whatever was made most recently as readily as what was made years ago. This instrument enumerates by substance, as its other cannabinoid searches show, and an enumerated schedule reaches the compounds it names and answers nothing about the rest. The determination was made on 20 September 2026.
Consequences if caught
Capital exposure: not established. That is a property of the label: each proved constituent must be classified first, and the constituent's schedule then determines whether Article 57, Article 58 or no capital route applies, so no label wide capital quantity can be stated. The spread is real on this class, because the dossier's cannabinoid searches record hexahydrocannabinol as a Schedule 1 entry with a quantity free Article 57 route and record other cannabinoid names as returning nothing at all. So two products both describable as synthetic cannabinoids can sit at opposite ends of that range, and the class word cannot distinguish them.
If prescribed or medical
No prescription question attaches to a chemical class label, because there is no entry for a prescription or a permit to evidence. The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule, which has no bearing here. Where a synthetic cannabinoid has a medicinal identity, the dossier's searches record dronabinol and nabilone as separately named substances, and any medical question belongs to the identified compound rather than to the class.
Documentation
There is nothing to document for a class label. Provenance: the constituent specific determination against the complete Decision No. 158 of 2025 schedules, recorded at «القنب الصناعي؛ الكانابينويدات الاصطناعية», was made on 20 September 2026. The practical point is that herbal material sprayed with one of these compounds carries no reliable indication of which one, and since the answer follows the compound, only an analysis produces a question that can be answered.
Primary sources
  • United Arab Emirates, Decision No. 158 of 2025, complete schedules
  • constituent specific determination for the chemical class label recorded at «القنب الصناعي؛ الكانابينويدات الاصطناعية», which the dossier records as not being one chemical entry
  • each proved constituent is classified first and its schedule then determines whether Article 57, Article 58 or no capital route applies, so no label wide capital quantity can be stated
  • the dossier's cannabinoid searches record hexahydrocannabinol as a Schedule 1 entry and dronabinol and nabilone as separately named substances, while other cannabinoid names returned nothing
  • read at https://sha.shj.ae/#:~:text=%D8%A7%D9%84%D8%AC%D8%AF%D8%A7%D9%88%D9%84%20%D8%A7%D9%84%D9%85%D8%B1%D9%81%D9%82%D8%A9
  • the instrument is written in Arabic and the English rendering is the dossier's
  • read as at 20 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in United Arab Emirates

Same substance, other countries